A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method

References

• Aho K, Derryberry D, Peterson T. (2014). Model selection for ecologists: the worldviews of AIC and BIC. Ecology 95:631–6.
   PubMed Web of Science ®Google Scholar
• Amundsen R, Asberg A, Ohm IK, Christensen H. (2012). Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro. Drug Metab Dispos 40:655–61.
   PubMed Web of Science ®Google Scholar
• Amundsen R, Christensen H, Zabihyan B, Asberg A. (2010). Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin. Drug Metab Dispos 38:1499–504.
   PubMed Web of Science ®Google Scholar
• Anguelova M, Karlsson J, Jirstrand M. (2012). Minimal output sets for identifiability. Math Biosci 239:139–53.
   PubMed Web of Science ®Google Scholar
• Baker M, Parton T. (2007). Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake. Xenobiotica 37:1110–34.
   PubMed Web of Science ®Google Scholar
• Bearup DJ, Evans ND, Chappell MJ. (2013). The input-output relationship approach to structural identifiability analysis. Comput Methods Programs Biomed 109:171–81.
   PubMed Web of Science ®Google Scholar
• Burnham KPA, Anderson DR. 2002. Information and likelihood theory. Model selection and multimodel inference: a practical information-theoretic approach. 2nd ed. New York: Springer, 60–80.
   Google Scholar
• Chang W. 2014. Extrafont: Tools for using fonts. R package version 0.17. Available from: https://CRAN.R-project.org/package=extrafont.
   Google Scholar
• Copeland RA. 2013. Reversible modes of inhibitor interactions with enzymes. Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. 2nd ed. New Jersey: John Wiley and Sons, 57–119.
   Google Scholar
• Evans ND, Chapman MJ, Chappell MJ, Godfrey KR. (2002). Identifiability of uncontrolled nonlinear rational systems. Automatica 38:1799–805.
   Web of Science ®Google Scholar
• Fricker G, Fahr A. (1997). Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action? Yale J Biol Med 70:379–90.
   PubMed Web of Science ®Google Scholar
• Fuentes AV, Pineda MD, Venkata KCN. (2018). Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. Pharmacy (Basel, Switzerland) 6:43.
   Google Scholar
• Grandjean TR, Chappell MJ, Lench AM, et al. (2014a). Experimental and mathematical analysis of in vitro Pitavastatin hepatic uptake across species. Xenobiotica 44:961–74.
   PubMed Web of Science ®Google Scholar
• Grandjean TR, Chappell MJ, Yates JW, Evans ND. (2014b). Structural identifiability analyses of candidate models for in vitro Pitavastatin hepatic uptake. Comput Methods Programs Biomed 114:e60–9.
   PubMed Web of Science ®Google Scholar
• Hagenbuch B, Gui C. (2008). Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38:778–801.
   PubMed Web of Science ®Google Scholar
• Harrison J, De Bruyn T, Darwich AS, Houston JB. (2018). Simultaneous assessment in vitro of transporter and metabolic processes in hepatic drug clearance: use of a media loss approach. Drug Metab Dispos 46:405–14.
   PubMed Web of Science ®Google Scholar
• Imamura R, Ichimaru N, Moriyama T, et al. (2005). Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus. Clin Transplant 19:616–21.
   PubMed Web of Science ®Google Scholar
• Ishigami M, Tokui T, Komai T, et al. (1995). Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat hepatocytes. Pharm Res 12:1741–5.
   PubMed Web of Science ®Google Scholar
• Jones HM, Barton HA, Lai Y, et al. (2012). Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data. Drug Metab Dispos 40:1007–17.
   PubMed Web of Science ®Google Scholar
• Karlsson J, Anguelova M, Jirstrand M. (2012). An efficient method for structural identifiability analysis of large dynamic systems. 16th IFAC Symposium on System Identification. Belgium: Elsevier, 941–6.
   Google Scholar
• Kimoto E, Li R, Scialis RJ, et al. (2015). Hepatic disposition of gemfibrozil and its major metabolite gemfibrozil 1-o-beta-glucuronide. Mol Pharm 12:3943–52.
   PubMed Web of Science ®Google Scholar
• Kolhatkar V, Polli JE. (2010). Reliability of inhibition models to correctly identify type of inhibition. Pharm Res 27: 2433–45.
   PubMed Web of Science ®Google Scholar
• Kulkarni P, Korzekwa K, Nagar S. (2016). Intracellular unbound atorvastatin concentrations in the presence of metabolism and transport. J Pharmacol Exp Ther 359:26–36.
   PubMed Web of Science ®Google Scholar
• Lau YY, Okochi H, Huang Y, Benet LZ. (2006). Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. J Pharmacol Exp Ther 316:762–71.
   PubMed Web of Science ®Google Scholar
• Lemahieu WP, Hermann M, Asberg A, et al. (2005). Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. Am J Transplant 5:2236–43.
   PubMed Web of Science ®Google Scholar
• Li L, Nouraldeen A, Wilson AG. (2013). Evaluation of transporter-mediated hepatic uptake in a non-radioactive high-throughput assay: a study of kinetics, species difference and plasma protein effect. Xenobiotica 43:253–62.
   PubMed Web of Science ®Google Scholar
• Liao M, Zhu Q, Zhu A, et al. (2018). Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans. Xenobiotica 49:852–62.
   PubMed Web of Science ®Google Scholar
• Lu C, Li P, Gallegos R, et al. (2006). Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes. Drug Metab Dispos 34:1600–5.
   PubMed Web of Science ®Google Scholar
• Menochet K, Kenworthy KE, Houston JB, Galetin A. (2012a). Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model. J Pharmacol Exp Ther 341:2–15.
   PubMed Web of Science ®Google Scholar
• Menochet K, Kenworthy KE, Houston JB, Galetin A. (2012b). Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes. Drug Metab Dispos 40:1744–56.
   PubMed Web of Science ®Google Scholar
• Paine SW, Parker AJ, Gardiner P, et al. (2008). Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes. Drug Metab Dispos 36:1365–74.
   PubMed Web of Science ®Google Scholar
• Patilea-Vrana G, Unadkat JD. (2016). Transport vs. metabolism: what determines the pharmacokinetics and pharmacodynamics of drugs? Insights from the extended clearance model. Clin Pharmacol Ther 100:413–8.
   PubMed Web of Science ®Google Scholar
• Prueksaritanont T, Koike M, Hoener BA, Benet LZ. (1992). Transport and metabolism of cyclosporine in isolated rat hepatocytes. The effects of lipids. Biochem Pharmacol 43:1997–2006.
   PubMed Web of Science ®Google Scholar
• Reinoso RF, Telfer BA, Brennan BS, Rowland M. (2001). Uptake of teicoplanin by isolated rat hepatocytes: comparison with in vivo hepatic distribution. Drug Metab Dispos 29:453–9.
   PubMed Web of Science ®Google Scholar
• Schwarz LR, Burr R, Schwenk M, et al. (1975). Uptake of taurocholic acid into isolated rat-liver cells. Eur J Biochem 55:617–23.
   PubMedGoogle Scholar
• Segel IH. 1993a. Kinetics of unireactant enzymes. Enzyme kinetics: behaviour and analysis of rapid equilibrium and steady-state enzyme systems. New Jersey: John Wiley and Sons Inc., 19–42.
   Google Scholar
• Segel IH. 1993b. Rapid equilibrium partial and mixed-type inhibition. Enzyme kinetics: behaviour and analysis of rapid equilibrium and steady-state enzyme systems. New Jersey: John Wiley and Sons Inc., 161.
   Google Scholar
• Seglen PO. (1976). Preparation of isolated rat liver cells. Methods Cell Biol 13:29–83.
   PubMedGoogle Scholar
• Shitara Y, Sugiyama Y. (2017). Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions. Pharmacol Ther 177:67–80.
   PubMed Web of Science ®Google Scholar
• Shitara Y. (2011). Clinical importance of OATP1B1 and OATP1B3 in drug-drug interactions. Drug Metab Pharmacokinet 26:220–7.
   PubMed Web of Science ®Google Scholar
• Shitara Y, Horie T, Sugiyama Y. (2006). Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 27:425–46.
   PubMed Web of Science ®Google Scholar
• Skalicka B, Kubanek M, Malek I, et al. (2009). Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin. J Heart Lung Transplant 28:598–604.
   PubMed Web of Science ®Google Scholar
• Soars MG, Grime K, Sproston JL, et al. (2007). Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859–65.
   PubMed Web of Science ®Google Scholar
• Soetaert K, Petzoldt T, Woodrow-Setzer R. (2010). Solving differential equations in R. R J 2:5–15.
   Google Scholar
• Umehara K, Camenisch G. (2012). Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat. Pharm Res 29:603–17.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Kusuhara H, Maeda K, et al. (2010). Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans. Drug Metab Dispos 38:215–22.
   PubMed Web of Science ®Google Scholar
• Wilke CO. 2016. Cowplot: Streamlined plot theme and plot annotations for 'ggplot2'. R package version 0.93. Available from: https://CRAN.R-project.org/package=cowplot
   Google Scholar
• Yabe Y, Galetin A, Houston JB. (2011). Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos 39:1808–14.
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Suzuki H, Hanano M, et al. (1993). Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol 264:G36–44.
   PubMed Web of Science ®Google Scholar
• Yoshikado T, Toshimoto K, Nakada T, et al. (2017). Comparison of methods for estimating unbound intracellular-to-medium concentration ratios in rat and human hepatocytes using statins. Drug Metab Dispos 45:779–89.
   PubMed Web of Science ®Google Scholar
• Ziegler K, Frimmer M. (1986). Identification of cyclosporin binding sites in rat liver plasma membranes, isolated hepatocytes, and hepatoma cells by photoaffinity labeling using [3H]cyclosporin-diaziridine. Biochim Biophys Acta 855:147–56.
   PubMedGoogle Scholar